Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000447:Aldehydes; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000201:enzymology; D002713:Chlorine; D003967:Diarrhea / Q000139:chemically induced; D004906:Erythrocyte Count; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008099:Liver / Q000201:enzymology; D008111:Liver Function Tests; D008113:Liver Neoplasms; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010088:Oxidoreductases / Q000378:metabolism
D000447:Aldehydes; D002713:Chlorine; D010088:Oxidoreductases; D008727:Methotrexate